INDIAN DRUGSPub Date : 2023-07-28DOI: 10.53879/id.60.07.13976
P. Devarajan, Bhagyashri K Joshi
{"title":"FEASIBILITY OF ZEBRAFISH LARVA MODEL AS A VIABLE SUBSTITUTE TO RAT NON-EVERTED SAC MODEL FOR PERMEATION EVALUATION OF BCS III DRUGS","authors":"P. Devarajan, Bhagyashri K Joshi","doi":"10.53879/id.60.07.13976","DOIUrl":"https://doi.org/10.53879/id.60.07.13976","url":null,"abstract":"The oral route is the most convenient route of drug administration. Many drugs exhibit poor oral bioavailability. BCS III drugs exhibit high solubility and present a massive challenge due to poor permeability. Different permeation enhancers viz., nonionic Cremophor® RH 40, Tween® 80 and Lutrol® F68, anionic docusate sodium with sodium cholate, and anionic polymer sodium carboxymethyl cellulose were evaluated using rat non-everted sac method and zebrafish larva model. Maximum permeation enhancement was seen with docusate sodium for both drugs. The permeation enhancement ratio for netilmicin sulphate was 4.07±0.657, while for deferoxamine mesylate it was 1.482±0.378. Cremophor® RH 40 enabled augmented flux of netilmicin sulphate, and Tween® 80 showed enhanced permeation of deferoxamine mesylate. An excellent correlation was observed between apparent permeability and flux with drug absorbed per zebrafish larva (µg) (R2 = 0.938) for netilmicin sulphate and for deferoxamine mesylate (R2 = 0.9397). An important outcome of the study is the demonstration of the feasibility of the zebrafish larvae model as a viable substitute to the non-everted sac method, which could also enable screening of potential permeation enhancers for the development of orally bioavailable formulations of BCS III.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46839942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-28DOI: 10.53879/id.60.07.13016
Akhil M. B., S. V. Kutty, Y. Haribabu, N. K.
{"title":"METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF PREGABALIN AND ETORICOXIB IN BULK AND PHARMACEUTICAL DOSAGE FORM BY UV-VISIBLE SPECTROSCOPY","authors":"Akhil M. B., S. V. Kutty, Y. Haribabu, N. K.","doi":"10.53879/id.60.07.13016","DOIUrl":"https://doi.org/10.53879/id.60.07.13016","url":null,"abstract":"A simple, accurate, precise and economical method has been developed for the simultaneous estimation of pregabalin and etoricoxib in combined dosage form by using double point standardization method. Methanol is used as the solvent and chromogenic agent added was bromocresol green. Bromocresol green is only reactive with pregabalin form a green colour ion pair complex. l max of pregabalin and etoricoxib was at 618 nm and 235 nm, respectively. The method was found to be linear in the range of 6-22 µg mL-1 for pregabalin and 4.8-17.6 µg mL-1 for etoricoxib. Validation parameters was performed and method was found to be linear, accurate, precise, rugged and robust.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49589285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-28DOI: 10.53879/id.60.07.12341
Ankush Goyal, Baljeet S. Kaur, Amandeep Kaur, V. Gupta, M. Gupta
{"title":"SYNTHESIS AND BIOLOGICAL ACTIVITY OF 2-(4-SUBSTITUTED BENZYLIDENE)- 7-METHYL-2H-THIAZOLO[3, 2-A] PYRIMIDINE-3,5-DIONES","authors":"Ankush Goyal, Baljeet S. Kaur, Amandeep Kaur, V. Gupta, M. Gupta","doi":"10.53879/id.60.07.12341","DOIUrl":"https://doi.org/10.53879/id.60.07.12341","url":null,"abstract":"The organosulphur thiazolo-pyrimidines are fused heterocyclic compounds that can be anticipated as 7-thio counterparts of the genuine purine bases such as guanine and adenine. They have attained a growing significance in the domain of drug chemistry because of their diverse pharmacological activities. In the current study, 2-substituted benzylidene-7-methyl-2H-thiazolo [3,2-a] pyrimidine-3,5-dione derivatives were synthesised. The synthetic compounds were tested against the human myelomonocytic leukaemia cell line (U-937) for their ability to inhibit cancer cell growth as well as against Gram negative E. coli (MTCC 40) and Gram positive S. aureus (MTCC 87) for their ability to inhibit bacterial growth. The amine and halogen containing compounds exhibited the strongest anticancer and antibacterial effects among all the derivatives in series (7a-j). Compounds 7h, 7e, 7a, 7b, 7c, 7i, and 7j displayed improved activity in both assays compared to standard andriyamycin and ciprofloxacin, whereas 7d, 7f, and 7g were shown to be moderately active. Through the use of IR, NMR and mass spectrum analyses, the molecular structures of the synthesized compounds were determined.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44388304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-28DOI: 10.53879/id.60.07.13351
Bhagyabhumi P. Shah, Vismay N. Patel, Samir K. Shah
{"title":"AMELIORATIVE EFFECT OF AVENA SATIVA (OAT) IN DINITROBENZENE SULPHONIC ACID INDUCED INFLAMMATORY BOWEL DISEASE IN RATS","authors":"Bhagyabhumi P. Shah, Vismay N. Patel, Samir K. Shah","doi":"10.53879/id.60.07.13351","DOIUrl":"https://doi.org/10.53879/id.60.07.13351","url":null,"abstract":"Inflammatory bowel disease (IBD) is a chronic relapsing gastrointestinal tract disease. There is an upsurge of IBD cases worldwide and there is no gold standard therapy and the drugs used to treat IBD are having many major side effects. Thus, there is a need for a better treatment option. This study aimed to evaluate the prophylactic role of Avena sativa (oat) in 2, 4-dinitro benzene sulphonic acid (DNBS) (120 mg kg-1) induced IBD in rats. Animals were randomly allocated to five groups- negative control, model control receiving only DNBS, group receiving A. sativa extract (500 mg kg-1 and 1 g kg-1 p.o.) and the last group receiving sulphasalazine (100 mg kg-1, p.o.). Colitis-induced rats treated with A. sativa and sulphasalazine restored their body weight, stool consistency, and bleeding in stool and significantly improved several biochemical parameters such as colonic glutathione content, lactate dehydrogenase, myeloperoxidase and lipid peroxides levels as compared to the model control group. Findings suggest that A. sativa possesses antioxidant and anti-inflammatory activity and can be useful in treating IBD.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47215980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-28DOI: 10.53879/id.60.07.13722
M. Momin, Vivek Basudkar, Sankalp Gharat, Anita Chando, T. Khan
{"title":"QUANTITATIVE ESTIMATION OF 6-GINGEROL, E-GUGGULSTERONE AND Z-GUGGULSTERONE IN A FIXED DOSE COMBINATION NANOEMULGEL BY RP-HPLC","authors":"M. Momin, Vivek Basudkar, Sankalp Gharat, Anita Chando, T. Khan","doi":"10.53879/id.60.07.13722","DOIUrl":"https://doi.org/10.53879/id.60.07.13722","url":null,"abstract":"Polyherbal formulations have proved to be efficacious for the therapeutic treatment of various diseases, However, the development of validated robust analytical methods for quantification is a major challenge. The aim of this project was to develop a simple analytical method for the quantification of 6-gingerol (6-GIN), E-guggulsterone (E-GGS) and Z-guggulsterone (Z-GGS) in nanoemulsion based gel using reverse phase high performance liquid chromatography (RP-HPLC). 6-GIN, E-GGS and Z-GGS were quantified using acetonitrile: water: methanol (70:20:10 V/V/V) as the mobile phase at 1.0 mL min-1 flow rate with photodiode array detection. The developed method was validated for linearity, accuracy, precision, specificity and robustness as per ICH Q2 (R1) guidelines. The drug content of the three actives in the developed nanoemulgel was found to be between 90% to 110% w/w. The developed analytical method is simple and can be used for quantification of 6-GIN, E-GGS and Z-GGS in fixed dose product containing these actives.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41696119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-28DOI: 10.53879/id.60.07.12845
D. Rani, M. Kaushik, Ranjit Singh
{"title":"EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CHIKUNGUNYA - A REVIEW","authors":"D. Rani, M. Kaushik, Ranjit Singh","doi":"10.53879/id.60.07.12845","DOIUrl":"https://doi.org/10.53879/id.60.07.12845","url":null,"abstract":"Chikungunya is a viral disease transmitted to humans by infected mosquitoes. Like most mosquito-borne infections, the virus can only be transmitted by blood-to-blood contact, through a mosquito bite or transfusion with infected blood. The disease is characterized by the common symptoms involving rashes, nausea and headache. In addition to this, it also causes intense joint pain and fever, which is known as arthralgia. It is widely spread in America, Africa and all over the world. The onset of chikungunya fever is more intense and the period of illness is shorter than that of dengue fever. Recently, chikungunya has become a serious public threat. The chikungunya symptoms are usually self-limiting and prophylactic treatment is currently unavailable to cure the disease, although various allopathic medicines, such as NSAID’s, analgesics, steroids, DMARDs and some anti-viral drugs claim to treat the disease. However, these medicines provide only symptomatic relief with serious side effects. Nowadays, researchers focus more towards an alternative treatment. The present review aims to highlight the epidemiology of chikungunya, treatment options available, and potential of alternative medicines for its treatment.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45442998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-03DOI: 10.53879/id.60.06.12743
U. Rani N., P. P, L. Tulasi S., T. Rao P.
{"title":"BIO-INSPIRED GREEN SYNTHESIS OF NICKEL NANOPARTICLES USING STERCULIA FOETIDA LEAF EXTRACT AND ITS APPLICATION FOR REMOVAL OF TRIVALENT CHROMIUM FROM AQUEOUS SOLUTION","authors":"U. Rani N., P. P, L. Tulasi S., T. Rao P.","doi":"10.53879/id.60.06.12743","DOIUrl":"https://doi.org/10.53879/id.60.06.12743","url":null,"abstract":"In the present work, a facile, eco-friendly, and cost-effective approach is described to remove Cr3+ toxic metal ions in an aqueous solution by nickel nanoparticles (NiNPs) synthesized via a green method utilizing Sterculia foetida leaf extract. The synthesized nickel nanoparticles were characterized by EDS (Energy- Dispersive X-Ray Spectroscopy), XRD (X-Ray diffraction), FT-IR (Fourier Transform Infrared Spectroscopy), and FE-SEM (Field Emission Scanning Electron Microscopy) spectroscopic methods. The spectroscopic signature studies revealed that the synthesized NiNPs are of spherical to irregular in shape with a mean particle size of 10±20 nm. The FT IR spectra confirmed the presence of OH, CC and CHO cross-linked stretching, CO and CCl stretching, representing the functional groups of polyphenols, flavonoids, and alkaloids type compounds in the synthesized nanoparticles. The EDS spectra confirmed the presence of nickel in the synthesized nanoparticles with a metal composition of 52.2%. In the XRD spectra, sharp diffraction peak two angles of green-produced NiNPs, which correspond to 111, 200 and 221 crystal planes, confirm the lattice structure of NiNPs. The synthesized NiNPs were used for the reduction of hexavalent chromium from aqueous solutions. The result revealed that immobilization of chromium heavy metals is an effect of initial concentration, ie. 100 µg mL-1 of Cr3+ concentration at 1 g L-1 of NiNPs adsorbent dosage within an average contact time of 1 h at 75 RPM. The present investigation revealed that these newly synthesized NiNPs might be potentially utilized for many environmental remediation applications.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46191974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-03DOI: 10.53879/id.60.06.13428
Shanti B. Mishra, Deeksha Singh, Amit K. Singh, Shradhanjali M Singh
{"title":"ENCAPSULATION OF THYME OIL INTO MICROSPONGES: PREPARATION, CHARACTERIZATION AND IN VITRO EVALUATION","authors":"Shanti B. Mishra, Deeksha Singh, Amit K. Singh, Shradhanjali M Singh","doi":"10.53879/id.60.06.13428","DOIUrl":"https://doi.org/10.53879/id.60.06.13428","url":null,"abstract":"Thyme essential oil (TEO) is a prominent essential oil reported to have diverse properties and biological activities including anti-inflammatory. This research aims to encapsulate TEO in prepared microsponges for the purpose of controlled drug delivery and reduce the frequency of drug administration by enhancing its bioavailability. For the preparation of TEO loaded microsponges, the quasi-emulsion diffusion technique was used by employing dichloromethane as solvent, polyvinyl alcohol as a stabilizer and ethyl cellulose as polymer. The formulation variables such as altering the concentration of PVA and EC were used for optimization and characterized by FTIR, SEM and evaluated for particle size, in vitro drug release and entrapment efficiency and further subjected for in vitro anti-inflammatory activity. results showed that all the dispersions were in the micro-size range with good entrapment efficiency and release profile. The percent inhibition of protein denaturation by TEO loaded microsponges was found within the significant range at various concentrations.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44374605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-03DOI: 10.53879/id.60.06.13908
Kaksha Sankha, M. Momin, T. Khan
{"title":"QUANTITATION OF GALLIC ACID IN ACACIA NILOTICA L. PODS BY HPTLC","authors":"Kaksha Sankha, M. Momin, T. Khan","doi":"10.53879/id.60.06.13908","DOIUrl":"https://doi.org/10.53879/id.60.06.13908","url":null,"abstract":"The pods of Acacia nilotica L. are traditionally used for versatile medical applications and are rich in polyphenolics and flavonoids. The pods powder is available in the market either as branded or unbranded products and it is imperative that their quality be assessed by a valid analytical method. This method will help to ensure the quality of the pod powder and can be used as a standardization tool prior to incorporation in finished herbal products. We report here a simple, precise and reproducible analytical method for standardization of the pods and solvent extracts of A. nilotica by HPTLC using gallic acid as the reference standard. This method can be used as a quality control tool to assess the quality of these pods when used as raw materials as such or in formulations.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41603791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INDIAN DRUGSPub Date : 2023-07-03DOI: 10.53879/id.60.06.12583
Anamika Singh, Tamanna Narsinghan
{"title":"BIOANALYTICAL METHOD VALIDATION: A COMPREHENSIVE ASSESSMENT OF VARIOUS REGULATORY GUIDELINES","authors":"Anamika Singh, Tamanna Narsinghan","doi":"10.53879/id.60.06.12583","DOIUrl":"https://doi.org/10.53879/id.60.06.12583","url":null,"abstract":"Bioanalytical methods are used to analyse an analyte in a biological matrix. Bioanalytical method validation is the process of determining the suitability of the given bioanalytical methodology for providing the required analytical data. Validation of the bioanalytical methods demonstrates and ensures that the methods used for the quantification of analyte in biological fluids are reliable, reproducible and suitable for its intended application. Different regulatory agencies like Food and Drug administration (FDA), The National Health Surveillance Agency or Agência Nacional de Vigilância Sanitária (ANVISA), European Medicines Evaluation Agency (EMA), Ministry of Health, Labor and Welfare (MHLW) and International Conference on Harmonization (ICH), provide guidelines for bioanalytical method validation. The present study provides an insight about the history of bioanalytical method validation including the details of various validation parameters and their description as per the different regulatory guidelines. The study also includes the parameters of ligand based assay methods and their description.","PeriodicalId":13409,"journal":{"name":"INDIAN DRUGS","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46670167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}